{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:15:20Z","timestamp":1774005320682,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004048","name":"Kashan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Systemic lupus erythematosus (SLE) as an autoimmune disease can relate to an imbalance between regulatory T cells (Tregs) and Th17 cells. Previous reports have shown that Myc-induced nuclear antigen (Mina) 53 protein is involved in the developments of Tregs and Th17 cells. Therefore, the current study focused on determining whether Mina53 level is correlated to the severity of SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The blood samples were collected from 60 patients with SLE (30 cases with mild SLE and 30 cases with severe SLE) and 30 healthy subjects. The serum concentration of Mina53 was measured using enzyme-linked immunosorbent assay (ELISA). The expression of Mina53 gene was assessed using real-time PCR method after extracting RNA from isolated peripheral blood mononuclear cells and synthesizing cDNA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with SLE showed significant increases in the serum level and gene expression of Mina53 compared to healthy subjects (P&amp;lt;0.001). Furthermore, serum level and gene expression of Mina53 showed significant effects on SLE disease and its severity (P&amp;lt;0.01). There was the highest sensitivity and maximum specificity in the cut-off point of Mina53 serum level equal to 125.4 (area under the curve (AUC)=0.951) and Mina53 expression level equal to 8.5 (AUC=0.88) for SLE diagnosis. The cut-off point of Mina53 serum level equal to 139.5 (AUC=0.854) and the cut-off point of Mina53 expression level equal to 8.5 (AUC=0.788) had the highest sensitivity and maximum specificity determining severe forms of SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our results showed that the changes in serum and expression levels of Mina53 have significant effects on SLE disease and its severity. These levels may be considered as diagnostic and predictive markers for SLE.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1370738","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T04:56:00Z","timestamp":1716872160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Predicting role of Myc-induced nuclear antigen 53 in determining the development and severity of systemic lupus erythematosus"],"prefix":"10.3389","volume":"15","author":[{"given":"Batool","family":"Zamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Dadgostar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Motedayyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Nikoueinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-021-05868-2","article-title":"Impacts of Fc\u03b3RIIB and Fc\u03b3RIIIA gene polymorphisms on systemic lupus erythematous disease activity index","volume":"14","author":"Karimifar","year":"2021","journal-title":"BMC Res Notes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/iji.12456","article-title":"Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus","volume":"47","author":"Fathi","year":"2020","journal-title":"Int J immunogenetics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2058738419863238","DOI":"10.1177\/2058738419863238","article-title":"Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus","volume":"33","author":"Fathi","year":"2019","journal-title":"Int J immunopathology Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann Rheumatic Diseases"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00152","article-title":"A structured classification and evaluation of current and future treatments for systemic lupus Erythematosus: Hochschule Rhein-Waal","volume":"8","author":"Abdelazim","year":"2023","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005248","article-title":"Multiple changes of gene expression and function reveal genomic and phenotypic complexity in SLE-like disease","volume":"11","author":"Wilbe","year":"2015","journal-title":"PLoS Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.155482","article-title":"Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis","volume":"6","author":"Frieri","year":"2015","journal-title":"J Pharmacol Pharmacotherapeutics"},{"key":"B8","article-title":"Neurologic complications of systemic lupus erythematosus, sj\u00f6gren syndrome, and rheumatoid arthritis","volume-title":"Semin Neurol.","author":"Bhattacharyya","year":"2014"},{"key":"B9","article-title":"Clinical manifestation, diagnosis, management, and treatment outcome of pericarditis in patients with systemic lupus erythematosus","volume":"97","author":"Buppajamrntham","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"B10","first-page":"56","article-title":"Incidence and associated risk factors of arterial stiffness in patients with systemic lupus erythematosus","volume":"43","author":"Ding","year":"2015","journal-title":"Zhonghua xin xue Guan Bing za zhi"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315588577","article-title":"Imaging of cardiovascular complications in patients with systemic lupus erythematosus","volume":"24","author":"Lin","year":"2015","journal-title":"Lupus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12862-018-1215-0","article-title":"Phylogenetic and genomic analyses of the ribosomal oxygenases Riox1 (No66) and Riox2 (Mina53) provide new insights into their evolution","volume":"18","author":"Br\u00e4uer","year":"2018","journal-title":"BMC evolutionary Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/172460080802300204","article-title":"Expression of Mina53 and its significance in gastric carcinoma","volume":"23","author":"Zhang","year":"2008","journal-title":"Int J Biol markers"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2009.00604.x","article-title":"Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma","volume":"40","author":"Ogasawara","year":"2010","journal-title":"Hepatol Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-009-0679-0","article-title":"Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH\/3T3 cells","volume":"136","author":"Komiya","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/or","article-title":"Expression of Myc target gene mina53 in subtypes of human lymphoma","volume":"18","author":"Teye","year":"2007","journal-title":"Oncol Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.620","article-title":"Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance","volume":"3","author":"Tan","year":"2012","journal-title":"Oncol letters"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2007.07.008","article-title":"Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma","volume":"42","author":"Fukahori","year":"2007","journal-title":"J Pediatr surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02156.x","article-title":"Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma","volume":"57","author":"Ishizaki","year":"2007","journal-title":"Pathol Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0543","article-title":"Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma","volume":"10","author":"Tsuneoka","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2918","article-title":"Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma","volume":"31","author":"Xing","year":"2014","journal-title":"Oncol Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1247\/csf.13006","article-title":"Ablation of Mina53 in mice reduces allergic response in the airways","volume":"38","author":"Mori","year":"2013","journal-title":"Cell structure Funct"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1747","article-title":"Mina, an Il4 repressor, controls T helper type 2 bias","volume":"10","author":"Okamoto","year":"2009","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2014.09.005","article-title":"Mina: a Th2 response regulator meets TGF\u03b2","volume":"31","author":"Pillai","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature11981","article-title":"Dynamic regulatory network controlling TH17 cell differentiation","volume":"496","author":"Yosef","year":"2013","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.placenta.2018.06.008","article-title":"Immunomodulatory effects of human amniotic epithelial cells on naive CD4+ T cells from women with unexplained recurrent spontaneous abortion","volume":"71","author":"Motedayyen","year":"2018","journal-title":"Placenta"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2018.04.002","article-title":"Human amniotic epithelial cells inhibit activation and pro-inflammatory cytokines production of naive CD4+ T cells from women with unexplained recurrent spontaneous abortion","volume":"18","author":"Motedayyen","year":"2018","journal-title":"Reprod Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/apl.2015.18.issue-6","article-title":"Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients","volume":"18","author":"Biswas","year":"2015","journal-title":"Int J rheumatic diseases"},{"key":"B29","first-page":"82","article-title":"Influence of 1 alpha, 25-dihydroxyvitamin D3 on T helper 17 cells and related cytokines in systemic lupus erythematosus","volume":"12","author":"Reihani","year":"2015","journal-title":"Iranian J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.18632\/oncotarget.v6i6","article-title":"Oncoprotein mdig contributes to silica-induced pulmonary fibrosis by altering balance between Th17 and Treg T cells","volume":"6","author":"Thakur","year":"2015","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheumatism"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-9841-7","article-title":"Potential effects of Mina53 on tumor growth in human pancreatic cancer","volume":"69","author":"Tan","year":"2014","journal-title":"Cell Biochem biophysics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2005.00572.x","article-title":"Expression of Mina53, a product of a Myc target gene in mouse testis","volume":"29","author":"Tsuneoka","year":"2006","journal-title":"Int J andrology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/iid3.191","article-title":"A SNP uncoupling Mina expression from the TGF\u03b2 signaling pathway","volume":"6","author":"Lian","year":"2018","journal-title":"Immunity Inflammation disease"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2010.0240","article-title":"Associations of the single-nucleotide polymorphisms of the Mina gene with the development of asthma in Chinese Han children: a case\u2013control study","volume":"15","author":"Chen","year":"2011","journal-title":"Genet testing Mol Biomarkers"},{"key":"B36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.18632\/genesandcancer.v6i7-8","article-title":"Current understanding of mdig\/MINA in human cancers","volume":"6","author":"Thakur","year":"2015","journal-title":"Genes Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41419-018-1084-x","article-title":"MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response","volume":"9","author":"Xuan","year":"2018","journal-title":"Cell Death disease"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2017.06.020","article-title":"DNA repair and systemic lupus erythematosus","volume":"56","author":"Meas","year":"2017","journal-title":"DNA repair"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0377-1237(10)80118-2","article-title":"Correlation between systemic lupus erythematosus disease activity index, C3, C4 and anti-dsDNA antibodies","volume":"66","author":"Narayanan","year":"2010","journal-title":"Med J Armed Forces India"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1370738\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T04:56:03Z","timestamp":1716872163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1370738\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2024.1370738"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1370738","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"article-number":"1370738"}}